Simulations Plus is fast tracking its consulting services for businesses working on coronavirus research, the company said in a statement Thursday.

The Lancaster drug modeling software company created its StrategiesPlus COVID-19 ACT program to provide specialized expertise to biopharma companies looking to create safe and effective treatments for the virus...

Join our Membership to get the full story.


Are you a current Member? Sign In